Substrate Fate in Activated Macrophages: A Comparison between Innate, Classic, and Alternative Activation
The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Macrophages play a relevant role in innate and adaptive immunity depending on the balance of the stimuli received. From an analytical and functional point of view, macrophage stimulation can be segregated into three main modes, as follows: innate, classic, and alternative pathways. These differential activations result in the expression of specific sets of genes involved in the release of pro- or anti-inflammatory stimuli. In the present work, we have analyzed whether specific metabolic patterns depend on the signaling pathway activated. A [1,2-13C2]glucose tracer-based metabolomics approach has been used to characterize the metabolic flux distributions in macrophages stimulated through the classic, innate, and alternative pathways. Using this methodology combined with mass isotopomer distribution analysis of the new formed metabolites, the data show that activated macrophages are essentially glycolytic cells, and a clear cutoff between the classic/innate activation and the alternative pathway exists. Interestingly, macrophage activation through LPS/IFN-γ or TLR-2, -3, -4, and -9 results in similar flux distribution patterns regardless of the pathway activated. However, stimulation through the alternative pathway has minor metabolic effects. The molecular basis of the differences between these two types of behavior involves a switch in the expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK2) from the liver type-PFK2 to the more active ubiquitous PFK2 isoenzyme, which responds to Hif-1α activation and increases fructose-2,6-bisphosphate concentration and the glycolytic flux. However, using macrophages targeted for Hif-1α, the switch of PFK2 isoenzymes still occurs in LPS/IFN-γ–activated macrophages, suggesting that this pathway regulates ubiquitous PFK2 expression through Hif-1α-independent mechanisms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“LPS causes a major shift in the metabolism of macrophages, dendritic cells, neutrophils and microglia from oxidative phosphorylation towards aerobic glycolysis, similar to what happens in tumor cells in a process known as the Warburg effect (Rodríguez-Prados et al., 2010) (Orihuela et al., 2016).”
From TET2 Regulates the Neuroinflammatory Response in Microglia (2019) · cites this paper as Rodríguez-Prados et al., 2010
In the citing paper
“Macrophages activated by the gram negative bacterial product lipopolysaccharide (LPS) switch their core metabolism from oxidative phosphorylation to glycolysis1.”
From Succinate is an inflammatory signal that induces IL-1β through HIF-1α (2013) · cites this paper as [1]
Citations
Cites
1 retracted
Frede, S., Stockmann, C., Winning, S., Freitag, P., & Fandrey, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802378 · Cited by 35
RetractedBioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
(1974) · Elsevier eBooks · doi:10.1016/b978-0-12-091304-6.x5001-0 · Cited by 6,755
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
(1985) · International Journal of Biochemistry · doi:10.1016/0020-711x(85)90098-9 · Cited by 3,478
Macrophage activation and polarization
Martinez, F. O. (2008) · Frontiers in Bioscience · doi:10.2741/2692 · Cited by 3,160
Martinez, F. O., Gordon, S., Locati, M., & Mantovani, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7303 · Cited by 2,125
Research works printed but not linked: 2
- Gutmann, 1974, Methods in Enzymatic Analysis, 1464
- Lee, 1998, Mass isotopomer study of the nonoxidative pathways of the pentose cycle with [1,2-13C2]glucose, Am. J. Physiol., 274, E843
Cited by
Items 101–126 of 126
Macrophage metabolism in atherosclerosis
Bories, G. F. P., & Leitinger, N. (2017) · FEBS Letters · doi:10.1002/1873-3468.12786 · Cited by 145
“Despr es JP, Fullerton HJ et al. (2016) Heart disease and stroke statistics—2016 update. Circulation 133, e38–e360. 89 Tabas I, Garc ıa-Carde~ na G and Owens GK (2015) Recent insights into the cellular biology of atherosclerosis.”
BackgroundInfluentialNémeth, B., Doczi, J., Csete, D., Kacso, G., Ravasz, D., Adams, D., Kiss, G., Nagy, A. M., Horvath, G., Tretter, L., et al. (2016) · The FASEB Journal · doi:10.1096/fj.15-279398 · Cited by 136
“This response is typical formacrophage cells upon activation of TLR, switching on aerobic glycolysis in addition to maintaining oxidative phosphorylation (44, 45), an effect that is also characteristic for tumor cells (46).”
BackgroundInflammasomes: sensors of metabolic stresses for vascular inflammation
Yang, X.-F. (2013) · Frontiers in Bioscience · doi:10.2741/4127 · Cited by 134
Metabolic communication in tumors: a new layer of immunoregulation for immune evasion
Ho, P.-C., & Liu, P.-S. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0109-1 · Cited by 124
Rac2 Controls Tumor Growth, Metastasis and M1-M2 Macrophage Differentiation In Vivo
Joshi, S., Singh, A. R., Zulcic, M., Bao, L., Messer, K., Ideker, T., Dutkowski, J., & Durden, D. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095893 · Cited by 128
“Recent metabolomic analysis done on macrophages suggest that classically activated M1 macrophages show relatively elevated glycolysis and oxidative pentose phosphate pathway (PPP) but reduced oxygen consumption via the TCA cycle compared to M2 cells [35].”
BackgroundHypoxia-inducible factors: crosstalk between inflammation and metabolism
Shay, J. E. S., & Celeste Simon, M. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.04.004 · Cited by 122
Self-defense of macrophages against oxidative injury: Fighting for their own survival
Virág, L., Jaén, R. I., Regdon, Z., Boscá, L., & Prieto, P. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101261 · Cited by 121
Self-citationThe Metabolic Microenvironment Steers Bone Tissue Regeneration
Loeffler, J., Duda, G. N., Sass, F. A., & Dienelt, A. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.11.008 · Cited by 113
Fan, N., Zhang, X., Zhao, W., Zhao, J., Luo, D., Sun, Y., Li, D., Zhao, C., Wang, Y., Zhang, H., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.73890 · Cited by 104
TET2 Regulates the Neuroinflammatory Response in Microglia
Carrillo-Jimenez, A., Deniz, Ö., Niklison-Chirou, M. V., Ruiz, R., Bezerra-Salomão, K., Stratoulias, V., Amouroux, R., Yip, P. K., Vilalta, A., Cheray, M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.013 · Cited by 104
Acidification of the intimal fluid: the perfect storm for atherogenesis
Öörni, K., Rajamäki, K., Nguyen, S. D., Lähdesmäki, K., Plihtari, R., Lee-Rueckert, M., & Kovanen, P. T. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r050252 · Cited by 101
“rate of glycolytic flux is greatly increased by classical activation (LPS+ IFN-), innate activation (LPS or other TLR agonists alone), but not by alternative activation (IL-4/IL-13; IL-10) (31).”
BackgroundNon-targeted metabolite profiling in activated macrophage secretion
Sugimoto, M., Sakagami, H., Yokote, Y., Onuma, H., Kaneko, M., Mori, M., Sakaguchi, Y., Soga, T., & Tomita, M. (2012) · Metabolomics · doi:10.1007/s11306-011-0353-9 · Cited by 95
Ruiz-García, A., Monsalve, E., Novellasdemunt, L., Navarro-Sabaté, À., Manzano, A., Rivero, S., Castrillo, A., Casado, M., Laborda, J., Bartrons, R., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190298 · Cited by 95
Bruce, K. D., Gorkhali, S., Given, K., Coates, A. M., Boyle, K. E., Macklin, W. B., & Eckel, R. H. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00057 · Cited by 94
“By contrast, acutely activated M1-like macrophages are shifted towards increased glycolysis (Rodríguez-Prados et al., 2010), activation of the pentose phosphate pathway (PPP; Haschemi et al.”
BackgroundTannahill, G. M., & O'Neill, L. A. J. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.008 · Cited by 84
“The molecular basis of increased glycolysis in response to TLR activation is poorly understood but a recent study highlights the importance of the bifunctional isoenzyme 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase (PFK2) [9].”
InfluentialThe Macrophage Response Is Driven by Mesenchymal Stem Cell-Mediated Metabolic Reprogramming
Luque-Campos, N., Bustamante-Barrientos, F. A., Pradenas, C., García, C., Araya, M. J., Bohaud, C., Contreras-López, R., Elizondo-Vega, R., Djouad, F., Luz-Crawford, P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.624746 · Cited by 82
“Likewise, several enzymes of the glycolytic route are up-regulated in M1 macrophage, such as an isoform of phosphofructokinase-2, u-PFK2, to potentiate the glycolytic flux (53, 54).”
BackgroundWong, J. H., Barron, A. M., & Abdullah, J. M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.687935 · Cited by 79
Macrophages in nonalcoholic fatty liver disease: a role model of pathogenic immunometabolism
Krenkel, O., & Tacke, F. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1604480 · Cited by 66
Regdon, Z., Robaszkiewicz, A., Kovács, K., Rygielska, Ż., Hegedűs, C., Bodoor, K., Szabó, É., & Virág, L. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.11.034 · Cited by 59
Hypoxia and hypoxia-inducible factors in myeloid cell-driven host defense and tissue homeostasis
Jantsch, J., & Schödel, J. (2015) · Immunobiology · doi:10.1016/j.imbio.2014.09.009 · Cited by 46
Energy metabolism and rheumatic diseases: from cell to organism
Spies, C. M., Straub, R. H., & Buttgereit, F. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3885 · Cited by 47
“In turn, MIF signaling via the MIF receptor CD74 is essential for hypoxiamediated HIF1α expression and HIF1 target gene induction involving ERK/mTOR activity complemented by PI3K activation upon mitogen stimulation [36].”
BackgroundInfluentialWeerasinghe, H., Simm, C., Djajawi, T. M., Tedja, I., Lo, T. L., Simpson, D. S., Shasha, D., Mizrahi, N., Olivier, F. A. B., Speir, M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112522 · Cited by 47
Weiss, R., Schilling, E., Grahnert, A., Kölling, V., Dorow, J., Ceglarek, U., Sack, U., & Hauschildt, S. (2015) · Innate Immunity · doi:10.1177/1753425915602545 · Cited by 41
Reprogramming of mitochondrial metabolism by innate immunity
Garaude, J. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.09.010 · Cited by 33
Jaén, R. I., Povo-Retana, A., Rosales-Mendoza, C., Capillas-Herrero, P., Sánchez-García, S., Martín-Sanz, P., Mojena, M., Prieto, P., & Boscá, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169114 · Cited by 20
Self-citationStrategies to promote liver fibrosis amelioration with involvement of restorative macrophages
Aquino, J. B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1792423 · Cited by 1
Metadata
- Authors
- Rodríguez-Prados, J.-C., Través, P. G., Cuenca, J., Rico, D., Aragonés, J., Martín-Sanz, P., Cascante, M., & Boscá, L.
- Affiliations
- Department of Biochemistry and Molecular Biology, Institute of Biomedicine, University of Barcelona , Madrid ,
- Consejo Superior de Investigaciones Científicas (ES)
- Spanish National Cancer Research Centre (ES)
- Hospital Universitario de La Princesa (ES)
- Instituto de Investigaciones Biomédicas ‘Alberto Sols’, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid , Madrid ,
- Institut de Biomedicina de la Universitat de Barcelona (ES)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-07-01
- Volume
- 185
- Issue
- 1
- Pages
- 605-614
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1548584275
- Cited by
- 1,022
- References
- 59
- Citations by year
- 2026: 40 · 2025: 58 · 2024: 70 · 2023: 67 · 2022: 94 · 2021: 101 · 2020: 119 · 2019: 102 · 2018: 70 · 2017: 75 · 2016: 63 · 2015: 58 · 2014: 41 · 2013: 38 · 2012: 14
- FWCI
- 8.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Keywords
- macrophage activation, macrophage polarization, alternative activation, macrophage metabolism, glycolysis, metabolic flux distribution, HIF-1α, Toll-like receptor signaling, mass isotopomer distribution analysis, 13C-glucose tracer
- MeSH terms
- Animals, Cells, Cultured, Enzyme Activation, Glycolysis, Immunity, Innate, Isoenzymes, Macrophage Activation, Mice, Inbred C57BL, Mice, Transgenic, Substrate Specificity, Signal Transduction, Macrophages, Peritoneal, Mice, Knockout, Gene Expression Profiling, Phosphofructokinase-2, Mice, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.